This inventor holds 4 USPTO granted patents and 5 published patent applications. Top assignees: Glaxosmithkline LLC, Glaxosmithkline Intellectual Property Development Limited. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 358 
1 out of 242 
Years Active: 2013-2017
Title: John Richard White: Innovator in Antibody Development
Introduction
John Richard White is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for various diseases. With a total of 4 patents, his work has the potential to impact the treatment of several types of cancer and other health conditions.
Latest Patents
Among his latest patents, one focuses on "Antibodies against the CXC-ELR family of chemokines." This invention relates to antibodies that treat diseases in which human IL-8, Gro-alpha, Gro-beta, Gro-gamma, GCP-2, and/or ENA-78 are implicated. Another significant patent is for "Antigen binding proteins," which includes antibodies that bind to HER3. This disclosure also covers polynucleotides encoding such antigen binding proteins, pharmaceutical compositions comprising these proteins, and methods of manufacture. The use of these antigen binding proteins is particularly relevant in the treatment or prophylaxis of diseases associated with breast cancer, ovarian cancer, prostate cancer, bladder cancer, pancreatic cancer, gastric cancer, melanoma, and other cancers that overexpress HER3.
Career Highlights
John Richard White has worked with prominent companies in the pharmaceutical industry, including GlaxoSmithKline LLC and GlaxoSmithKline Intellectual Property Development Limited. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the field of therapeutics.
Collaborations
Throughout his career, John has collaborated with talented individuals such as Zdenka Ludmila Jonak and Alexander Harrison Taylor. These partnerships have likely enhanced the innovation and effectiveness of his research efforts.
Conclusion
John Richard White's contributions to antibody development and cancer treatment exemplify the impact of innovative thinking in biotechnology. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile